Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Filings indexed 1,482 across all filing types
Latest filing 2023-09-14 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 13 September 2023.
Director's Dealing Classification · 100% confidence The document details a transaction involving a person discharging managerial responsibilities (or a closely associated person) regarding shares of Sopharma AD. Specifically, it reports the 'Nature of the transaction' as 'Buy' and lists the price and volume of shares traded on a specific date (13.9.2023). This structure—reporting personal share transactions by directors/executives—perfectly matches the definition of Director's Dealing. This is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K) as it focuses on insider trading disclosure, not financial performance. It is a specific regulatory disclosure concerning insider transactions.
2023-09-14 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 13 September 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction report concerning an individual, Ognian Donev, who is an Executive director and chairman of the Board of directors of Sopharma AD. The report specifies the nature of the transaction as 'Sell' of 'Shares' (ISIN № BG11SOSOBT18) along with prices and volumes. This structure is characteristic of mandatory disclosures regarding insider trading or transactions by persons discharging managerial responsibilities (PDMRs) under regulations like MAR (Market Abuse Regulation in the EU). Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reports detailing personal share transactions by company directors and executives.
2023-09-14 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 for the exercise of warrants from 11 September 2023.
Director's Dealing Classification · 100% confidence The document explicitly states in the title: "Current report: 127/ 13.09.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This directly corresponds to the reporting of personal share transactions by company directors and executives (insider trades), which matches the definition for Director's Dealing (DIRS). The content details the person involved, their status, the issuer, and the nature of the transaction (exercising warrant rights related to shares/instruments).
2023-09-13 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 for the exercise of warrants from 11 Sep...
Director's Dealing Classification · 100% confidence The document text details a notification concerning a transaction involving a person discharging managerial responsibilities (or a closely associated person) at Sopharma AD. Specifically, it mentions 'Details of the person discharging managerial responsibilities/person closely associated', 'Position/status', and 'Details of the transaction(s)'. The nature of the transaction is 'Exercising warrant rights for conditional capital increase'. This structure and content strongly indicate a mandatory disclosure of insider trading or executive transactions, which falls under the category of Director's Dealing (DIRS) or potentially a specific type of Capital/Financing Update (CAP). However, the primary focus is reporting the transaction by an insider/director's associate. In regulatory contexts, reports detailing personal share transactions by directors and executives are classified as Director's Dealing (DIRS).
2023-09-13 English
Notification from "Sofprint Group" AD under Art. 19 of Regulation (EU) No 596/2014 of 12 September 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "Current report: 125/ 13.09.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This regulation (MAR - Market Abuse Regulation) governs the disclosure of transactions conducted by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. The content details the name of the associated person, their position, the issuer, and the nature of the transaction (Sell) involving warrants. This directly corresponds to the definition of Director's Dealing (insider trades). Therefore, the appropriate filing type is DIRS.
2023-09-13 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 12 September 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains the heading "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy) involving a person discharging managerial responsibilities or a closely associated person ('Donev Investments Holding AD') in financial instruments ('Warrants'). This structure and content directly correspond to regulatory filings reporting insider trading activities. This matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2023-09-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.